The negative impact of tobacco smoking on survival after prostate cancer diagnosis

Cancer Causes and Control

Volumn 26, Issue 9, 2015, Pages 1299-1305

  Polesel, Jerry ^a   Gini, Andrea ^a   Dal Maso, Luigino ^a   Stocco, Carmen ^b   Birri, Silvia ^a   Taborelli, Martina ^a   Serraino, Diego ^a   Zucchetto, Antonella ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

Author keywords

Cohort; Prostate cancer; Prostate cancer death; Smoking; Survival

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SPECIFIC SURVIVAL; COHORT ANALYSIS; GLEASON SCORE; HUMAN; ITALIAN (CITIZEN); LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSTATE CANCER; RETROSPECTIVE STUDY; SMOKING; ADVERSE EFFECTS; CANCER GRADING; CASE CONTROL STUDY; CAUCASIAN; PATHOLOGY; PROGNOSIS; PROSTATE TUMOR; RISK FACTOR; SURVIVAL RATE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; PROGNOSIS; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING; SURVIVAL RATE;

EID: 84943207495     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-015-0624-2     Document Type: Article

References (23)

1. Etzioni R, Tsodikov A, Mariotto A, Szabo A, Falcon S, Wegelin J, Di Tommaso D, Karnofski K, Gulati R, Penson DF, Feuer E (2008) Quantifying the role of PSA screening in the US prostate cancer mortality decline. Cancer Causes Control 19:175–181
2. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2013) GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 11. IARC: Lyon, France. http://globocan.iarc.fr. Accessed 16 Feb 2015
3. Verdecchia A, Guzzinati S, Francisci S, De Angelis R, Bray F, Allemani C, Tavilla A, Santaquilani M, Sant M, EUROCARE Working Group (2009) Survival trends in European cancer patients diagnosed from 1988 to 1999. Eur J Cancer 45:1042–1066
4. Islami F, Moreira DM, Boffetta P, Freedland SJ (2014) A systematic review and meta-analysis of tobacco use and prostate cancer mortality and incidence in prospective cohort studies. Eur Urol 66:1054–1064
5. Zu K, Giovannucci E (2009) Smoking and aggressive prostate cancer: a review of the epidemiologic evidence. Cancer Causes Control 20:1799–1810
6. Moreira DM, Aronson WJ, Terris MK, Kane CJ, Amling CL, Cooperberg MR, Boffetta P, Freedland SJ (2014) Cigarette smoking is associated with an increased risk of biochemical disease recurrence, metastasis, castration-resistant prostate cancer, and mortality after radical prostatectomy: results from the SEARCH database. Cancer 120:197–204
7. Murta-Nascimento C, Romero AI, Sala M, Lorente JA, Bellmunt J, Rodero NJ, Lloreta J, Hospital A, Burón A, Castells X, Macià F (2014) The effect of smoking on prostate cancer survival: a cohort analysis in Barcelona. Eur J Cancer Prev 24:335–339
8. Stone NN, Stock RG (2014) 15-year cause specific and all-cause survival following brachytherapy for prostate cancer: negative impact of long-term hormonal therapy. J Urol 192:754–759
9. Steinberger E, Kollmeier M, McBride S, Novak C, Pei X, Zelefsky MJ (2014) Cigarette smoking during external beam radiation therapy for prostate cancer is associated with an increased risk of prostate cancer-specific mortality and treatment-related toxicity. BJU Int. doi: 10.1111/bju.12969
10. Kenfield SA, Stampfer MJ, Chan JM, Giovannucci E (2011) Smoking and prostate cancer survival and recurrence. JAMA 305:2548–2555
11. Joshu CE, Mondul AM, Meinhold CL, Humphreys EB, Han M, Walsh PC, Platz EA (2011) Cigarette smoking and prostate cancer recurrence after prostatectomy. J Natl Cancer Inst 103:835–838
12. Gong Z, Agalliu I, Lin DW, Stanford JL, Kristal AR (2008) Cigarette smoking and prostate cancer-specific mortality following diagnosis in middle-aged men. Cancer Causes Control 19:25–31
13. Pantarotto J, Malone S, Dahrouge S, Gallant V, Eapen L (2007) Smoking is associated with worse outcomes in patients with prostate cancer treated by radical radiotherapy. BJU Int 99:564–569
14. Dal Maso L, Zucchetto A, La Vecchia C, Montella M, Conti E, Canzonieri V, Talamini R, Tavani A, Negri E, Garbeglio A, Franceschi S (2004) Prostate cancer and body size at different ages: an Italian multicentre case-control study. Br J Cancer 90:2176–2180
15. Dal Maso L, Zucchetto A, Talamini R, Serraino D, Stocco CF, Vercelli M, Falcini F, Franceschi S (2008) Effect of obesity and other lifestyle factors on mortality in women with breast cancer. Int J Cancer 123:2188–2194
16. D’Avanzo B, La Vecchia C, Katsouyanni K, Negri E, Trichopoulos D (1996) Reliability of information on cigarette smoking and beverage consumption provided by hospital controls. Epidemiology 7:312–315
17. Kalbfleisch JD, Prentice RL (2002) The statistical analysis of failure time data. Wiley, New York
18. Giovannucci E, Liu Y, Plats EA, Stampfer MJ, Willett WC (2007) Risk factors for prostate cancer incidence and progression in the health professional follow-up study. Int J Cancer 121:1571–1578
19. Sopori ML, Kozak W (1998) Immunomodulatory effects of cigarette smoke. J Neuroimmunol 83:148–156
20. Kalra R, Singh SP, Savage SM, Finch GL, Sopori ML (2000) Effects of cigarette smoke on immune response: chronic exposure to cigarette smoke impairs antigen-mediated signaling in T cells and depletes IP3-sensitive Ca(2+) stores. J Pharmacol Exp Ther 293:166–171
21. Crocetti E, AIRTUM Working Group (2007) Tumore della prostata: trend di incidenza e di mortalità. Epid Prev 31:100
22. Ho T, Howard LE, Vidal AC, Gerber L, Moreira D, McKeever M, Andriole G, Castro-Santamaria R, Freedland SJ (2014) Smoking and risk of low and high-grade prostate cancer: results from the REDUCE study. Clin Cancer Res 20:5331–5338
23. AIRTUM Working Group (2014) Italian cancer figures, report 2014: prevalence and cure of cancer in Italy. Epidemiol Prev 38(6 Suppl 1):1–122